Clinical Trials in Arlington, United States
Locations / Arlington, United States
Delta Trials lists 18 clinical trials conducted in Arlington, United States, making it a notable site of clinical research activity. These trials addressing 23 medical conditions, reflecting the scope and diversity of clinical research in this location. Since 2020, 1 trial in this location have been terminated before reaching their primary endpoint. This dataset is refreshed continuously as trial statuses are updated on ClinicalTrials.gov, capturing longitudinal changes in the Arlington research landscape.
18
Total Trials
23
Conditions
1
Terminated since 2020
Browse by condition (23 total)
- Plaque psoriasis 2 trialsAll Plaque psoriasis trials
- Dermatitis atopic 2 trialsAll Dermatitis atopic trials
- Psoriasis 2 trialsAll Psoriasis trials
- Colorectal neoplasms 2 trialsAll Colorectal neoplasms trials
- Mixed guttate/plaque psoriasis 1 trialAll Mixed guttate/plaque psoriasis trials
- Esophageal adenocarcinoma 1 trialAll Esophageal adenocarcinoma trials
- Severe chronic plaque psoriasis 1 trialAll Severe chronic plaque psoriasis trials
- Metastatic gastric cancer 1 trialAll Metastatic gastric cancer trials
- Major depressive disorder (mdd) 1 trialAll Major depressive disorder (mdd) trials
- All Moderate chronic plaque psoriasis trials
- Alzheimers disease 1 trialAll Alzheimers disease trials
- All Squamous cell carcinoma of head and neck trials
- Chronic kidney disease 1 trialAll Chronic kidney disease trials
- Hyperlipidemia 1 trialAll Hyperlipidemia trials
- Diabetes 1 trialAll Diabetes trials
- Untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma 1 trialAll Untreated advanced or metastatic gastric, gastroesophageal junction , or esophageal adenocarcinoma trials
- Cardiovascular risk 1 trialAll Cardiovascular risk trials
- End stage renal disease 1 trialAll End stage renal disease trials
- Multiple myeloma 1 trialAll Multiple myeloma trials
- Gastroesophageal junction cancer 1 trialAll Gastroesophageal junction cancer trials